341 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (1936)
- Addiction (18)
- Allergy, Asthma, & Immunology (13)
- All of Us Research Program - NIH (1)
- Autoimmune Disorders (28)
- Blood Disorders (39)
- Bone & Muscle (10)
- Cancer (749)
- Child Development (4)
- COVID-19 (Coronavirus) (36)
- Critical Illness (1)
- Dental (2)
- Diabetes (21)
- Ear, Nose and Throat (11)
- Endocrine & Metabolic Disease (12)
- Eye (7)
- Gastrointestinal and Digestive Diseases (26)
- Hair and Skin Disorders (2)
- Headaches (5)
- Healthy Volunteers (182)
- Heart Disease (128)
- Infectious Disease (47)
- Insomnia (2)
- Kidney Disease (12)
- Liver Disease (47)
- Lung Disease (31)
- Meniere's Disease (1)
- (-) Neurological Disorders (180)
- Nutrition (5)
- Obesity (9)
- Obstetrics & Gynecology (52)
- Pain Management (1)
- Pediatrics (102)
- Psychiatric Disorders (64)
- Rehabilitation (8)
- Stroke (7)
- Surgery (7)
- Transplant (52)
- Urology (4)
- Vascular Conditions (10)
Displaying 201 - 203 of 203
Condition: Neurological Disorders / Brain Tumors
Investigator: Andrew Lassman, MD
Status: Closed
The purpose of this study is to find out whether study drug bortezomib with radiation therapy and Temozolomide is safe when given to patients with brain tumors. This study will also evaluate the side effects and see whether the combination of bortezomib with radiation and Temozolomide can be effective in shrinking tumors. Bortezomib is the investigational…
Condition: Neurological Disorders / Alzheimer's Disease
Investigator: Lawrence Honig, MD, PhD
Status: Closed
The name of this trial is MissionAD. This is a 24-month treatment, multicenter, double-blind, placebo-controlled, parallel group, Phase 3 study in participants with Early Alzheimer's Disease (AD), includingmild cognitive impairment (MCI) due to AD, known as Prodromal AD, and the early stages of mild AD.The study will be conducted to evaluate the…
Condition: Neurological Disorders / Alzheimer's Disease
Investigator: Lawrence Honig, MD, PhD
Status: Closed
The purpose of this study is to test the effects of an investigational drug called crenezumab for the treatment of Alzheimers disease. This study will use MRI scans to look at the effects of this treatment on the brain. This study will be conducted in many centers around the world, and it is important that the MRI scans are always performed in a similar…
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website,
you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the
Columbia University Website Cookie Notice.
I AGREE